| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Saturday, August 20, 2022 9:12:25 PM
Was thinking along the same lines and not just because it would add huge $value$ to revive because of continuous demand, but most importantly, imo, it would provide life altering relief to millions suffering with the debilitating effects of long covid worldwide.
My investor sense keeps tingling when i look at whats happening here and how baffling the trading is and how eerily silent certain people are about this trial, and the company.....something just doesnt add up but thats just me.
If we're spot on about bucci's potential for diverse applications it could be that we've all stumbled across ""King Solomons Mines"".....metaphorically speaking of course .
Btw....PSM (Penny Stock Mentality) could end up costing some a bundle!!!
Time will tell....................
My investor sense keeps tingling when i look at whats happening here and how baffling the trading is and how eerily silent certain people are about this trial, and the company.....something just doesnt add up but thats just me.
If we're spot on about bucci's potential for diverse applications it could be that we've all stumbled across ""King Solomons Mines"".....metaphorically speaking of course .
Btw....PSM (Penny Stock Mentality) could end up costing some a bundle!!!
Time will tell....................
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
